Drug firm Aurobindo Pharma on Monday said its board has approved the appointment of PV Ramprasad Reddy as Executive Chairman of Aurobindo Pharma USA, Inc.
“Board of Directors of the company at its meeting held on August 25, 2012, has approved the proposal of appointment of PV Ramprasad Reddy as Executive Chairman of Aurobindo Pharma USA, Inc, the wholly-owned subsidiary of the company w.e.f. December 1, 2012,” Aurobindo Pharma said in a filing to BSE.
The said proposal is subject to further approval of the shareholders of the company, it added.
Accordingly, an extra ordinary general meeting (EGM) of the company is being convened on September 27, 2012, the company said.
Consequent to his proposed appointment in the company’s US subsidiary, the board has also approved Reddy relinquishing the executive responsibilities as whole time director of the firm and his continuation as a non-executive director of the company not liable to retire by rotation with effect from December 1, 2012, it added.
Shares of Aurobindo Pharma were trading at Rs 112.75 on BSE in afternoon, up 0.80 per cent from its previous close.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.